The Lampard Inquiry hears from experts about Oxevision technology.

An inquiry into the deaths of 2,000 people in Essex is expected to continue into 2027 There is no "strong independent evidence" that a monitoring system used widely in mental health wards has improved patient safety, an inquiry has heard. The Lampard Inquiry is examining the deaths of more than 2,000 mental health patients in Essex over a 24-year period. The inquiry had previously heard "grave concerns" expressed about the widespread use of Oxevision technology, which monitors patients in their rooms using infrared sensors and cameras. LIO Health, which runs Oxevision, recently said: "Technology has a vital role to play in supporting safer inpatient mental health care, an area without any medical device technology until Oxevision." "In one trust alone, the technology has helped staff in responding to 1,453 safety incidents over a four-year period," LIO Health said. They had reviewed 45 studies that were used to justify introducing Oxevision across the NHS. The academics found some of the studies involved employees of Oxevision or were not extensive enough.